Rigel Pharmaceuticals Inc (RIGL) — Financial Flexibility Index
Rigel Pharmaceuticals Inc (RIGL) has a Financial Flexibility Index of 0.32x as of June 2026. Free cash flow of $30.65 Million (operating CF $30.65 Million minus capex $0.00) represents 0% of total liabilities ($95.42 Million). Check Rigel Pharmaceuticals Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Rigel Pharmaceuticals Inc Financial Flexibility Index (1999–2025)
Historical Financial Flexibility Index trend for Rigel Pharmaceuticals Inc across 27 annual periods. For the full cash flow conversion analysis, see Rigel Pharmaceuticals Inc cash flow conversion.
Annual Financial Flexibility Index for Rigel Pharmaceuticals Inc (1999–2025)
Year-by-year free cash flow to debt coverage for Rigel Pharmaceuticals Inc. Explore Rigel Pharmaceuticals Inc (RIGL) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.62x | $75.66 Million | $75.66 Million | $122.11 Million | ▲ +212.4% |
| 2024 | 0.20x | $31.87 Million | $31.47 Million | $160.69 Million | ▲ +212.5% |
| 2023 | 0.06x | $9.26 Million | $-5.74 Million | $145.87 Million | ▲ +112.8% |
| 2022 | -0.50x | $-73.31 Million | $-73.76 Million | $147.90 Million | ▼ -1143.6% |
| 2021 | 0.05x | $6.50 Million | $5.88 Million | $136.95 Million | ▲ +107.1% |
| 2020 | -0.67x | $-50.92 Million | $-52.19 Million | $76.35 Million | ▼ -56.1% |
| 2019 | -0.43x | $-40.05 Million | $-41.51 Million | $93.75 Million | ▲ +78.4% |
| 2018 | -1.97x | $-57.72 Million | $-58.83 Million | $29.23 Million | ▲ +52.9% |
| 2017 | -4.19x | $-77.39 Million | $-77.56 Million | $18.46 Million | ▼ -29.0% |
| 2016 | -3.25x | $-75.08 Million | $-75.89 Million | $23.11 Million | ▼ -473.6% |
| 2015 | -0.57x | $-22.87 Million | $-23.41 Million | $40.37 Million | ▲ +78.8% |
| 2014 | -2.68x | $-69.34 Million | $-69.75 Million | $25.89 Million | ▲ +43.8% |
| 2013 | -4.76x | $-84.84 Million | $-86.06 Million | $17.81 Million | ▼ -22.0% |
| 2012 | -3.91x | $-81.81 Million | $-85.19 Million | $20.95 Million | ▼ -22.0% |
| 2011 | -3.20x | $-67.07 Million | $-69.38 Million | $20.96 Million | ▼ -230.8% |
| 2010 | 2.45x | $50.30 Million | $46.74 Million | $20.56 Million | ▲ +173.6% |
| 2009 | -3.32x | $-102.64 Million | $-102.78 Million | $30.88 Million | ▼ -30.6% |
| 2008 | -2.54x | $-101.01 Million | $-103.52 Million | $39.69 Million | ▼ -66.8% |
| 2007 | -1.53x | $-51.27 Million | $-52.21 Million | $33.61 Million | ▼ -13.6% |
| 2006 | -1.34x | $-34.92 Million | $-35.84 Million | $26.01 Million | ▼ -57.2% |
| 2005 | -0.85x | $-33.38 Million | $-35.17 Million | $39.08 Million | ▲ +38.1% |
| 2004 | -1.38x | $-36.61 Million | $-38.15 Million | $26.52 Million | ▲ +31.2% |
| 2003 | -2.01x | $-31.20 Million | $-32.44 Million | $15.55 Million | ▼ -15.3% |
| 2002 | -1.74x | $-32.89 Million | $-34.53 Million | $18.90 Million | ▼ -138.9% |
| 2001 | -0.73x | $-12.75 Million | $-15.98 Million | $17.51 Million | ▼ -39.4% |
| 2000 | -0.52x | $-7.97 Million | $-11.59 Million | $15.25 Million | ▼ -1051.4% |
| 1999 | -0.05x | $-745.00K | $-7.83 Million | $16.41 Million | — |